|
Instil Bio Inc (NASDAQ: TIL) |
|
Instil Bio Inc
TIL's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Instil Bio Inc growth rates, revenue grew
in III. Quarter 2024 from the same quarter a year ago.
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 13.29 %
Instil Bio Inc net loss increased from $-19 millions, to $-23 millions in III. Quarter 2024,
• More on TIL's Growth
|
|
Instil Bio Inc realized a net loss in trailing twelve months.
Instil Bio Inc realized cash reduction of $ -2.57 per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 82.89.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.15.
• More on TIL's Valuation
|
|
|
|
|
Instil Bio Inc realized net loss in trailing twelve months.
Instil Bio Inc realized cash outflow of $ -2.57per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 82.89.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.15.
Instil Bio Inc Price to Book Ratio is at 0.7 higher than Industry Avg. of -0, and higher than S&P 500 Avg. of 0.01
• More on TIL's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com